
ARRY-382
CAS No. 1313407-95-2
ARRY-382( ARRY382 )
Catalog No. M28026 CAS No. 1313407-95-2
ARRY-382 is a highly selective oral inhibitor of CSF-1R with an IC50 of 9 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 413 | Get Quote |
![]() ![]() |
10MG | 606 | Get Quote |
![]() ![]() |
25MG | 954 | Get Quote |
![]() ![]() |
50MG | 1287 | Get Quote |
![]() ![]() |
100MG | 1737 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameARRY-382
-
NoteResearch use only, not for human use.
-
Brief DescriptionARRY-382 is a highly selective oral inhibitor of CSF-1R with an IC50 of 9 nM.
-
DescriptionARRY-382 is a highly selective oral inhibitor of CSF-1R with an IC50 of 9 nM.
-
In Vitro——
-
In Vivo——
-
SynonymsARRY382
-
PathwayTyrosine Kinase
-
TargetCSF1R
-
RecptorPDE10A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1313407-95-2
-
Formula Weight564.68
-
Molecular FormulaC32H36N8O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1cccc(Cn(c2ccc3)nc(C4CC4)c2c3NC(c2cnc3n2ccc(OCCN2CCN(C)CC2)c3)=O)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hamaguchi W, et al. Synthesis and in vivo evaluation of novel quinoline derivatives as phosphodiesterase 10A inhibitors. Chem Pharm Bull (Tokyo). 2014;62(12):1200-1213.
molnova catalog



related products
-
JNJ-28312141
JNJ-28312141 is a potent, orally active CSF-1 receptor (CSF-1R) kinase inhibitor with IC50 of 0.69 nM.
-
BLZ945
BLZ945 (BLZ-945) is a potent, selective, brain-penetrant CSF-1R inhibitor with biochemical IC50 of 1 nM.
-
JTE-952
JTE-952 (JTE952) is a potent, selective colony stimulating factor-1 receptor (CSF1R) type II inhibitor with IC50 of 14 nM.